Established: 2000
Type: Graduated from Technological Incubator

Core business
Combinatorial biology screening technology of libraries in the drug discovery field.

Overview
"SoAP" is a new combinatorial biology technology, in the drug discovery field, which was devised by the company to overcome the drawbacks of similar methods.

Three subjects make the "SoAP" technology superior:

•  The lead compounds which are the products of the technology.
• They should not only be binders of their targets, but also functional in whatever action they were meant to have on their targets (for instance binders vs. deactivators). 
• They should be isolated in an unparalleled short time - of only a few days.

Since "SoAP" is a combinatorial technology, almost any illness or condition could be addressed to. The drugs that can be developed from the isolated lead compounds should be much more specific than most of the drugs used today, and thus be more efficient and have almost no side effects.

The short-term plan of the company is to construct the "SoAP" system and to produce in two-three years a few attractive lead compounds that would be able to be further processed into new therapeutic drugs or diagnostic kits.
The revenues of the company would come from licensing the "SoAP" technology and selling lead compounds to pharmaceutical corporations.